Cargando…

Prognostic value of sarcopenia in patients treated by Radiochemotherapy for locally advanced oesophageal cancer

BACKGROUND: Sarcopenia is defined by a loss of skeletal muscle mass with or without loss of fat mass. Sarcopenia has been associated to reduced tolerance to treatment and worse prognosis in cancer patients, including patients undergoing surgery for limited oesophageal cancer. Concomitant chemo-radio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mallet, Romain, Modzelewski, Romain, Lequesne, Justine, Mihailescu, Sorina, Decazes, Pierre, Auvray, Hugues, Benyoucef, Ahmed, Di Fiore, Fréderic, Vera, Pierre, Dubray, Bernard, Thureau, Sébastien
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7245030/ https://www.ncbi.nlm.nih.gov/pubmed/32443967 http://dx.doi.org/10.1186/s13014-020-01545-z

Ejemplares similares

Prognostic value of low skeletal muscle mass in patient treated by exclusive curative radiochemotherapy for a NSCLC
por: Mallet, R., et al.
Publicado: (2021)

Prospective Evaluation of Sarcopenia in Head and Neck Cancer Patients Treated with Radiotherapy or Radiochemotherapy
por: Thureau, Sébastien, et al.
Publicado: (2021)

Monitoring tumour response during chemo-radiotherapy: a parametric method using FDG-PET/CT images in patients with oesophageal cancer
por: Vera, Pierre, et al.
Publicado: (2014)

FDG and FMISO PET-guided dose escalation with intensity-modulated radiotherapy in lung cancer
por: Thureau, Sébastien, et al.
Publicado: (2018)

Impact of the Bayesian penalized likelihood algorithm (Q.Clear®) in comparison with the OSEM reconstruction on low contrast PET hypoxic images
por: Texte, Edgar, et al.
Publicado: (2020)

First Comparison between [18f]-FMISO and [18f]-Faza for Preoperative Pet Imaging of Hypoxia in Lung Cancer
por: Thureau, Sébastien, et al.
Publicado: (2021)

Deep learning analysis of contrast-enhanced spectral mammography to determine histoprognostic factors of malignant breast tumours
por: Dominique, Caroline, et al.
Publicado: (2022)

Advances in PET and MRI imaging of tumor hypoxia
por: Gouel, Pierrick, et al.
Publicado: (2023)

Trimodality PET/CT/MRI and Radiotherapy: A Mini-Review
por: Decazes, Pierre, et al.
Publicado: (2021)

Evaluation of a Dedicated Software “Elements™ Spine SRS, Brainlab(®)” for Target Volume Definition in the Treatment of Spinal Bone Metastases With Stereotactic Body Radiotherapy
por: Rogé, Maximilien, et al.
Publicado: (2022)

Evaluation of an Automatic Classification Algorithm Using Convolutional Neural Networks in Oncological Positron Emission Tomography
por: Pinochet, Pierre, et al.
Publicado: (2021)

Quantitative MRI to Characterize Hypoxic Tumors in Comparison to FMISO PET/CT for Radiotherapy in Oropharynx Cancers
por: Gouel, Pierrick, et al.
Publicado: (2023)

Clinical and phantom validation of a deep learning based denoising algorithm for F-18-FDG PET images from lower detection counting in comparison with the standard acquisition
por: Bonardel, Gerald, et al.
Publicado: (2022)

Prognostic value of post-induction chemotherapy (18)F-FDG PET-CT in stage II/III non-small cell lung cancer before (chemo-) radiation
por: Ganem, Julien, et al.
Publicado: (2019)

Characterization of positioning uncertainties in PET‐CT‐MR trimodality solutions for radiotherapy
por: Hinault, Pauline, et al.
Publicado: (2022)

Predictive value of initial FDG-PET features for treatment response and survival in esophageal cancer patients treated with chemo-radiation therapy using a random forest classifier
por: Desbordes, Paul, et al.
Publicado: (2017)

Angiogenesis imaging study using interim [(18)F] RGD-K5 PET/CT in patients with lymphoma undergoing chemotherapy: preliminary evidence
por: Tonnelet, David, et al.
Publicado: (2021)

A Quantitative Comparison between Shannon and Tsallis–Havrda–Charvat Entropies Applied to Cancer Outcome Prediction
por: Brochet, Thibaud, et al.
Publicado: (2022)

Correction: Brochet et al. A Quantitative Comparison between Shannon and Tsallis–Havrda–Charvat Entropies Applied to Cancer Outcome Prediction. Entropy 2022, 24, 436
por: Brochet, Thibaud, et al.
Publicado: (2022)

Development of Novel (111)-In-Labelled DOTA Urotensin II Analogues for Targeting the UT Receptor Overexpressed in Solid Tumours
por: Poret, Benjamin, et al.
Publicado: (2020)

Neoadjuvant versus definitive radiochemotherapy of locoregionally advanced oesophageal cancer—who benefits?
por: Schiffner, Christoph, et al.
Publicado: (2022)

A new methodology to derive 3D kinetic parametric FDG PET images based on a mathematical approach integrating an error model of measurement
por: Colard, Elyse, et al.
Publicado: (2018)

Comparison of heterogeneity quantification algorithms for brain SPECT perfusion images
por: Modzelewski, Romain, et al.
Publicado: (2012)

Weakly Supervised Tumor Detection in PET Using Class Response for Treatment Outcome Prediction
por: Amyar, Amine, et al.
Publicado: (2022)

Safety and outcome of definitive chemoradiotherapy in elderly patients with oesophageal cancer
por: Tougeron, D, et al.
Publicado: (2008)

Radiochemotherapy
Publicado: (1998)

Delineation of lung cancer with FDG PET/CT during radiation therapy
por: Ganem, J., et al.
Publicado: (2018)

PD-1 and PD-L1 expression predict regression and prognosis following neoadjuvant radiochemotherapy of oesophageal adenocarcinoma
por: Göbel, Holger H., et al.
Publicado: (2022)

The impact of sarcopenia on survival and treatment tolerance in patients with head and neck cancer treated with chemoradiotherapy
por: Bentahila, Rita, et al.
Publicado: (2022)

ExacTrac X-Ray 6D Imaging During Stereotactic Body Radiation Therapy of Spinal and Nonspinal Metastases
por: Hadj Henni, Ahmed, et al.
Publicado: (2023)

SPECT-computed tomography in rats with TNBS-induced colitis: A first step toward functional imaging
por: Marion-Letellier, Rachel, et al.
Publicado: (2017)

Prognostic value of baseline metabolic tumour volume in advanced-stage Hodgkin’s lymphoma
por: Pinochet, Pierre, et al.
Publicado: (2021)

Association of Radiochemotherapy to Immunotherapy in unresectable locally advanced Oesophageal carciNoma—randomized phase 2 trial ARION UCGI 33/PRODIGE 67: the study protocol
por: Modesto, Anouchka, et al.
Publicado: (2023)

Immunotherapy by Immune Checkpoint Inhibitors and Nuclear Medicine Imaging: Current and Future Applications
por: Decazes, Pierre, et al.
Publicado: (2020)

Combined Radiochemotherapy: Metalloproteinases Revisited
por: Waller, Verena, et al.
Publicado: (2021)

Accelerated hyperfractionated radiochemotherapy with temozolomide is equivalent to normofractionated radiochemotherapy in a retrospective analysis of patients with glioblastoma
por: Lewitzki, Victor, et al.
Publicado: (2019)

Reproducibility of Baseline Tumour Metabolic Volume Measurements in Diffuse Large B-Cell Lymphoma: Is There a Superior Method?
por: Eude, Florian, et al.
Publicado: (2021)

The prognostic value of sarcopenia in oesophageal cancer: A systematic review and meta‐analysis
por: Fang, Pinhao, et al.
Publicado: (2022)

Using 18F-FDG-PET/CT Metrics to Predict Survival in Ra-Dio-Iodine Refractory Thyroid Cancers
por: Roy, Malanie, et al.
Publicado: (2022)

Impact of Radiochemotherapy on Immune Cell Subtypes in High-Grade Glioma Patients
por: Dutoit, Valérie, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_jg9hh8o4af1m1vvtl7ripkpngu